ATE276768T1 - Arzneimittel gegen hepatitis - Google Patents
Arzneimittel gegen hepatitisInfo
- Publication number
- ATE276768T1 ATE276768T1 AT99909297T AT99909297T ATE276768T1 AT E276768 T1 ATE276768 T1 AT E276768T1 AT 99909297 T AT99909297 T AT 99909297T AT 99909297 T AT99909297 T AT 99909297T AT E276768 T1 ATE276768 T1 AT E276768T1
- Authority
- AT
- Austria
- Prior art keywords
- hepatitis
- poly
- drugs
- present
- dioleoylglycerol
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
- A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6905—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion
- A61K47/6911—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion the form being a liposome
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Dispersion Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Gastroenterology & Hepatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Steroid Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP7605598 | 1998-03-24 | ||
| PCT/JP1999/001438 WO1999048531A1 (fr) | 1998-03-24 | 1999-03-23 | Nouveaux remedes contre l'hepatite |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE276768T1 true ATE276768T1 (de) | 2004-10-15 |
Family
ID=13594103
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99909297T ATE276768T1 (de) | 1998-03-24 | 1999-03-23 | Arzneimittel gegen hepatitis |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US7205282B1 (de) |
| EP (1) | EP1064950B1 (de) |
| JP (1) | JP3804452B2 (de) |
| KR (1) | KR100520738B1 (de) |
| CN (1) | CN1200736C (de) |
| AT (1) | ATE276768T1 (de) |
| AU (1) | AU2855099A (de) |
| CA (1) | CA2325550A1 (de) |
| DE (1) | DE69920418T2 (de) |
| MY (1) | MY134896A (de) |
| RU (1) | RU2226102C2 (de) |
| WO (1) | WO1999048531A1 (de) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69942581D1 (de) * | 1998-05-25 | 2010-08-26 | Nippon Shinyaku Co Ltd | Verfahren zur herstellung einer nucleinsäure enthaltenden kompositzusammenstellung |
| CA2459373A1 (en) * | 2001-09-04 | 2003-03-20 | Nippon Shinyaku Co., Ltd. | Method of evaluating efficacy of nucleic acid therapy |
| DE10361502A1 (de) * | 2003-12-23 | 2005-07-28 | Phenion Gmbh & Co. Kg | Kosmetische oder pharmazeutische Zubereitungen enthaltend Superstruktur-bildende Nukleinsäure-Sequenzen |
| JP4721642B2 (ja) * | 2004-01-20 | 2011-07-13 | サントリーホールディングス株式会社 | 肝障害を伴う肝臓疾患の予防又は改善剤 |
| EP1886688A4 (de) | 2005-05-30 | 2013-01-09 | Nippon Shinyaku Co Ltd | Verfahren zur herstellung einer zubereitung eines nukleinsäurehaltigen komplexes |
| JP5347510B2 (ja) | 2007-02-05 | 2013-11-20 | 日本新薬株式会社 | ポリエチレングリコール誘導体 |
| US20100152433A1 (en) * | 2007-03-19 | 2010-06-17 | Michinori Kohara | Antiviral agent |
| CA2727428A1 (en) * | 2008-06-19 | 2009-12-23 | Nippon Shinyaku Co., Ltd. | Drug carrier |
| EA019268B1 (ru) * | 2010-12-01 | 2014-02-28 | Общество С Ограниченной Ответственностью "Анвилаб" | Комбинированное средство, обладающее гепатопротекторным действием |
| CN105824410B (zh) * | 2016-02-22 | 2017-09-15 | 维沃移动通信有限公司 | 一种自动滚屏阅读方法及移动终端 |
| CN110433173A (zh) * | 2019-07-19 | 2019-11-12 | 成都市海通药业有限公司 | 聚肌胞注射液及用于降低聚肌胞注射液内毒素的方法 |
| CN116354836A (zh) * | 2022-03-25 | 2023-06-30 | 深圳市新合生物医疗科技有限公司 | 阳离子脂质化合物及其制备方法和应用、以及mRNA递送系统 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4140761A (en) * | 1977-04-11 | 1979-02-20 | The United States Of America As Represented By The Department Of Health, Education & Welfare | Modification of hepatitis B virus infection in chronic carriers of hepatitis B surface antigen |
| US5049386A (en) | 1985-01-07 | 1991-09-17 | Syntex (U.S.A.) Inc. | N-ω,(ω-1)-dialkyloxy)- and N-(ω,(ω-1)-dialkenyloxy)Alk-1-YL-N,N,N-tetrasubstituted ammonium lipids and uses therefor |
| US5298614A (en) * | 1986-01-06 | 1994-03-29 | Nippon Shinyaku Co. Ltd. | Size limited double stranded poly I poly(cytidylate/4-thiouridylate) |
| KR100283601B1 (ko) * | 1993-02-19 | 2001-03-02 | 아만 히데아키 | 글리세롤 유도체, 디바이스 및 의약 조성물 |
| TW524693B (en) | 1997-10-16 | 2003-03-21 | Nippon Shinyaku Co Ltd | Cancer cell nuclease activator |
-
1999
- 1999-03-23 JP JP2000537578A patent/JP3804452B2/ja not_active Expired - Fee Related
- 1999-03-23 AU AU28550/99A patent/AU2855099A/en not_active Abandoned
- 1999-03-23 KR KR10-2000-7010449A patent/KR100520738B1/ko not_active Expired - Fee Related
- 1999-03-23 RU RU2000126741/15A patent/RU2226102C2/ru not_active IP Right Cessation
- 1999-03-23 CA CA002325550A patent/CA2325550A1/en not_active Abandoned
- 1999-03-23 WO PCT/JP1999/001438 patent/WO1999048531A1/ja not_active Ceased
- 1999-03-23 EP EP99909297A patent/EP1064950B1/de not_active Expired - Lifetime
- 1999-03-23 MY MYPI99001091A patent/MY134896A/en unknown
- 1999-03-23 AT AT99909297T patent/ATE276768T1/de not_active IP Right Cessation
- 1999-03-23 DE DE69920418T patent/DE69920418T2/de not_active Expired - Lifetime
- 1999-03-23 CN CNB998043338A patent/CN1200736C/zh not_active Expired - Fee Related
- 1999-03-23 US US09/646,135 patent/US7205282B1/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| DE69920418D1 (de) | 2004-10-28 |
| AU2855099A (en) | 1999-10-18 |
| EP1064950A4 (de) | 2002-11-27 |
| KR20010042093A (ko) | 2001-05-25 |
| WO1999048531A1 (fr) | 1999-09-30 |
| CN1294518A (zh) | 2001-05-09 |
| EP1064950A1 (de) | 2001-01-03 |
| JP3804452B2 (ja) | 2006-08-02 |
| DE69920418T2 (de) | 2005-10-06 |
| CN1200736C (zh) | 2005-05-11 |
| EP1064950B1 (de) | 2004-09-22 |
| RU2226102C2 (ru) | 2004-03-27 |
| KR100520738B1 (ko) | 2005-10-12 |
| CA2325550A1 (en) | 1999-09-30 |
| US7205282B1 (en) | 2007-04-17 |
| MY134896A (en) | 2007-12-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE4497905T1 (de) | Pharmazeutische Zusammensetzung zur Prävention und Behandlung des Motion-Sickness-Syndroms | |
| EP1001782A4 (de) | 5,6-HETEROARYL-DIPYRIDO (2-3-b:3',2'-f) AZEPINE UND DEREN VERWENDUNG ZUR PROPHYLAXE UND BEHANDLUNG VON HIV-INFEKTIONEN | |
| PL372925A1 (en) | Prevention and treatment of restenosis by local administration of drug | |
| EA200200812A1 (ru) | Фармацевтическая композиция, содержащая низкую дозу энтекавира, и ее применение | |
| ATE276768T1 (de) | Arzneimittel gegen hepatitis | |
| AU2002236765A1 (en) | Pharmaceutical combination for the treatment of cancer containing a 4-quinazolineamine and another anti-neoplastic agent | |
| ATE185562T1 (de) | Taxol derivate, deren herstellung und diese enthaltende pharmazeutischen zusammenstellungen | |
| DE60115029D1 (de) | Pharmazeutische zusammensetzungen enthaltend cannabidiol-derivate | |
| PL342162A1 (en) | Galenic form for oral administration of either immediate or prolonged drug release containing an absorption enhancing agent and application of such absorption enhancing agent | |
| AU7476894A (en) | Method of treating atherosclerosis or restenosis using microtubule stabilizing agent | |
| NZ334124A (en) | Use of the chelating agent clioquinol, with vitamin B12 for the manufacture of a pharmaceutical composition for the treatment of alzheimer's disease | |
| BR0207961A (pt) | Combinação de análogos da epotilona e agentes quimioterápicos para o tratamento de doenças proliferativas | |
| PT1040830E (pt) | Medicamento para doencas neurodegenerativas | |
| KR930016102A (ko) | 과증식 혈관 질환 치료용 조성물 | |
| ATE207743T1 (de) | Pharmazeutische präparate zur gezielten behandlung von morbus crohn und colitis ulcerosa | |
| DE69527506D1 (de) | Delta 12,16-isotaxol analoge mit antineoplastischer wirkung und pharmazeutische zusammensetzungen sie enthaltend | |
| ATE232100T1 (de) | Gegen magensaft geschützte omeprazol- mikrogranülen, herstellungsverfahren und pharmazeutische zubereitungen | |
| ITMI922603A1 (it) | Composizioni farmaceutiche comprendenti un farmaco, una sostanza polimerica reticolata, un olio ed un agente tensioattivo | |
| ATE324886T1 (de) | Feste arzneizusammensetzung enthaltend 4'-cyano- trifluoro-3-(4-fluorophenylsulphonyl) -2-hydroxy- 2-methylpropiono- m toluidide und pvp | |
| IL149134A0 (en) | Pharmaceutical compositions containing tofisopam | |
| NZ513650A (en) | Pharmaceutical composition for the treatment of urinary incontinence, motion sickness and vertigo | |
| ATE212829T1 (de) | Feste, wasserfreie, pharmazeutische zubereitungen für vaginale verwendung | |
| HUP9600455A3 (en) | Use of quinoxalines combined with protease-inhibiting compounds for producing pharmaceutical compositions for treating aids and/or hiv infections | |
| DE4494713T1 (de) | Arylsulfonamidderivate und diese Derivate enthaltende Arzneimittel | |
| HUP9802897A3 (en) | Optically active pyridyl-4h-1,2,4-oxadiazine derivatives, the use thereof in the treatment of vascular diseases and pharmaceutical composition containing the compound as active ingredient |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |